Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0001209191-23-059039

President & CEO sold 40,000 shares at an average $39.70 ($1,588,186)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kurtz Ronald M MD President & CEO 2023-12-14 Sale 10b5-1 −20,000 $40.01 $800,164 909,610 I
Kurtz Ronald M MD President & CEO 2023-12-14 Sale 10b5-1 −20,000 $39.40 $788,022 889,610 I
Open-market sales · 40,000 sh · avg $39.70 · $1,588,186
Loading xslF345X05/doc4.xml…